These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4425844)

  • 1. Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.
    Cameron JS; Chantler C; Ogg CS; White RH
    Br Med J; 1974 Oct; 4(5935):7-11. PubMed ID: 4425844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
    Bajpai A; Bagga A; Hari P; Dinda A; Srivastava RN
    Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term cyclophosphamide in corticosteroid treated childhood nephrosis.
    Sheth KJ; Liu CC; Good TA
    Wis Med J; 1974 May; 73(5):S55-60. PubMed ID: 4830366
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis.
    Al-Khader AA; Lien JW; Aber GM
    Clin Nephrol; 1979 Jan; 11(1):26-30. PubMed ID: 428152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome.
    McCrory WW; Shibuya M; Lu WH; Lewy JE
    J Pediatr; 1973 Apr; 82(4):614-8. PubMed ID: 4698338
    [No Abstract]   [Full Text] [Related]  

  • 6. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome.
    Chiu J; Drummond KN
    J Pediatr; 1974 Jun; 84(6):825-30. PubMed ID: 4855503
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
    Ponticelli C; Edefonti A; Ghio L; Rizzoni G; Rinaldi S; Gusmano R; Lama G; Zacchello G; Confalonieri R; Altieri P
    Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.
    Barratt TM; Bercowsky A; Osofsky SG; Soothill JF
    Lancet; 1975 Jan; 1(7898):55-8. PubMed ID: 46019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
    de Moor R; de Jong M; Monnens L
    Ned Tijdschr Geneeskd; 1992 May; 136(18):876-80. PubMed ID: 1589052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.
    Lancet; 1974 Aug; 2(7878):423-7. PubMed ID: 4137139
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclophosphamide in the treatment of idiopathic nephrotic syndrome.
    Pennisi AJ; Grushkin CM; Lieberman E
    Pediatrics; 1976 Jun; 57(6):948-51. PubMed ID: 934751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA; Levtchenko EN; Wetzels JF
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome.
    Uldall PR; Feest TG; Morley AR; Tomlinson BE; Kerr DN
    Lancet; 1972 Jun; 1(7763):1250-3. PubMed ID: 4113514
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term assessment of cyclophosphamide therapy for nephrosis in children.
    McDonald J; Murphy AV; Arneil GC
    Lancet; 1974 Oct; 2(7887):980-2. PubMed ID: 4138088
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclophosphamide therapy in the nephrotic syndrome in childhood.
    Moncrieff MW; White RH; Oggs CS; Cameron JS
    Br Med J; 1969 Mar; 1(5645):666-71. PubMed ID: 5774315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of cyclophosphamide and azathioprine in Nigerian children with the nephrotic syndrome and poorly selective proteinuria.
    Adeniyi A; Hendrickse RG; Soothill JF
    Arch Dis Child; 1979 Mar; 54(3):204-7. PubMed ID: 373645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide therapy in frequently relapsing nephrotic syndrome with and without steroid dependence.
    Srivastava RN; Agarwal RK; Choudhry VP; Moudgil A; Bhuyan UN; Sunderam KR
    Int J Pediatr Nephrol; 1985; 6(4):245-50. PubMed ID: 4093243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential protein clearances and response to treatment in Nigerian nephrotic children.
    Adeniyi A; Hendrickse RG; Soothill JF
    Arch Dis Child; 1976 Sep; 51(9):691-6. PubMed ID: 793539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
    Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.